Amphastar Pharmaceuticals Inc vs BHP Billiton Limited — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while BHP Billiton Limited trades at $90.9 (market cap $227.94B). The key difference: BHP Billiton Limited is far larger — about 263.8× Amphastar Pharmaceuticals Inc's market cap, and BHP Billiton Limited pays a 2.94% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | BHP | |
|---|---|---|
Market Cap | $863.95M | $227.94B |
Sector | Health | Basic Materials |
52-Week High | $30.81 | $93.15 |
52-Week Low | $16.87 | $52.14 |
Enterprise Value | $1.26B | $242.14B |
Dividend Yield | — | 2.94% |
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
No Aura AI signal available yet.
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →